DE602005010387D1 - Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom - Google Patents

Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom

Info

Publication number
DE602005010387D1
DE602005010387D1 DE602005010387T DE602005010387T DE602005010387D1 DE 602005010387 D1 DE602005010387 D1 DE 602005010387D1 DE 602005010387 T DE602005010387 T DE 602005010387T DE 602005010387 T DE602005010387 T DE 602005010387T DE 602005010387 D1 DE602005010387 D1 DE 602005010387D1
Authority
DE
Germany
Prior art keywords
formulation
extract
treatment
metabolic syndrome
fatibleity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005010387T
Other languages
German (de)
English (en)
Inventor
Marcin Krotkiewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCANDINAVIAN CLINICAL NUTRITIO
Original Assignee
SCANDINAVIAN CLINICAL NUTRITIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCANDINAVIAN CLINICAL NUTRITIO filed Critical SCANDINAVIAN CLINICAL NUTRITIO
Publication of DE602005010387D1 publication Critical patent/DE602005010387D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005010387T 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom Expired - Fee Related DE602005010387D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL364411A PL209905B1 (pl) 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
PCT/EP2005/000206 WO2005067952A1 (en) 2004-01-15 2005-01-12 Formulation for treating obesity and associated metabolic syndrome

Publications (1)

Publication Number Publication Date
DE602005010387D1 true DE602005010387D1 (de) 2008-11-27

Family

ID=34793496

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010387T Expired - Fee Related DE602005010387D1 (de) 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom

Country Status (13)

Country Link
US (1) US20090175969A1 (ru)
EP (1) EP1708726B1 (ru)
JP (1) JP2007517830A (ru)
KR (1) KR100826863B1 (ru)
CN (1) CN1946415A (ru)
AT (1) ATE411033T1 (ru)
AU (1) AU2005205031A1 (ru)
CA (1) CA2584191A1 (ru)
DE (1) DE602005010387D1 (ru)
NO (1) NO20063655L (ru)
PL (1) PL209905B1 (ru)
RU (1) RU2334523C2 (ru)
WO (1) WO2005067952A1 (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
GB0520956D0 (en) 2005-10-14 2005-11-23 Med Eq As Chewing gum
ES2438765T3 (es) 2005-11-04 2014-01-20 Inqpharm Group Sdn Bhd Composición a base de plantas para el control del peso
EP2001561A2 (en) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance
JP2010506957A (ja) 2006-10-20 2010-03-04 ダウ グローバル テクノロジーズ インコーポレイティド メタボリックシンドロームを予防または処置するための水溶性セルロース誘導体の使用
CA2686419A1 (en) * 2007-05-04 2008-11-13 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
RU2465787C1 (ru) * 2008-10-03 2012-11-10 СИГМА АЛИМЕНТОС, С.А. де К.В. Композиция, способствующая регуляции общего холестерина и холестерина лпнп, и/или потере веса, и/или термогенезу
CN102170798B (zh) * 2008-10-03 2013-06-12 西格马食品可变资本有限公司 用于促进对总胆固醇和ldl胆固醇的控制和/或体重减轻和/或生热作用的组合物
FR2938735B1 (fr) * 2008-11-21 2012-12-28 Holymark Composition amaigrissante, en particulier pour sportifs, administrable par voie orale et complement alimentaire integrant une telle composition.
KR20100124519A (ko) * 2009-05-19 2010-11-29 (주)아모레퍼시픽 녹차 추출물을 함유하는 조성물
CN102370589B (zh) * 2010-08-11 2013-02-13 迪特克(济源)绿色生物科技有限公司 一种减肥霜及其制备方法
CN103327999B (zh) 2011-01-21 2016-08-10 狮王株式会社 促进脂肪分解组合物
US20130177506A1 (en) * 2011-10-27 2013-07-11 Parker E. Atkins Bio-Available Chlorogenic Acid Preparations for Supplemental Human Consumption and Use
DE202014100439U1 (de) * 2014-01-17 2014-02-25 Pm-International Ag Pulverförmige Zusammensetzung zur Herstellung eines Nahrungsmittelersatzes
CA2983823A1 (en) * 2015-04-24 2016-10-27 Tru-Science, Llc Plant extracts for the treatment of excess weight and obesity
CN107302997A (zh) * 2016-04-19 2017-10-31 林秀霞 一种抑制脂肪蓄积的组合物及其用途
CN107638569A (zh) * 2016-07-21 2018-01-30 上海聿健生物科技有限公司 增强褐色脂肪细胞产热效率的方法和应用
US20200367547A1 (en) * 2017-03-21 2020-11-26 Pharmachem Laboratories, Llc Controlled release of phaseolamin compositions
WO2019173339A1 (en) * 2018-03-05 2019-09-12 Pure Care Pro Llc Natural combination products and methods for regulation of kidney and excretory system function
KR102267472B1 (ko) * 2018-10-24 2021-06-21 전남대학교산학협력단 녹차 카테킨을 포함하는 중성지방 저감용 식품 조성물, 대사성 질환 개선용 식품 조성물 및 대사성 질환 예방 또는 치료용 약학 조성물
CN113116955B (zh) * 2021-02-24 2022-10-04 中国药科大学 一种含植物提取物的药物组合物及其应用
JP2024008717A (ja) * 2022-07-08 2024-01-19 株式会社常磐植物化学研究所 カフェイン除去マテ抽出物、抗肥満用組成物、カフェイン除去方法及びマテ抽出物の製造方法
KR20240011314A (ko) 2022-07-19 2024-01-26 대구한의대학교산학협력단 과라나 추출물을 포함하는 지방 분화 유도 억제, 지방 합성 억제 및 혈장 콜레스테롤 생성 억제용 조성물, 약학 조성물 및 건강기능식품

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
FR2712191B1 (fr) * 1993-11-08 1996-03-08 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
US5804596A (en) 1997-02-27 1998-09-08 Sabinsa Corporation Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
JPH10265328A (ja) * 1997-03-27 1998-10-06 Nippon Flour Mills Co Ltd 化粧料、ペットフード、リパーゼ阻害剤及びそれを含む食品
US6143301A (en) * 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
JP4783882B2 (ja) * 1999-11-17 2011-09-28 三邦株式会社 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
JP2003528904A (ja) * 2000-04-04 2003-09-30 カラー アクセス，インコーポレイティド 皮膚の脂質バリア機能を改善するための組成物
JP4795511B2 (ja) * 2000-07-14 2011-10-19 日本サプリメント株式会社 α−グルコシダーゼ阻害剤の製造法
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
CA2478663A1 (en) * 2002-03-11 2003-09-18 General Nutrition Investment Company Methods for the treatment and prevention of overweight in mammals
US7279184B2 (en) * 2003-10-24 2007-10-09 Herbalscience, Llc Methods and compositions comprising Ilex

Also Published As

Publication number Publication date
CN1946415A (zh) 2007-04-11
RU2006129486A (ru) 2008-02-20
EP1708726B1 (en) 2008-10-15
NO20063655L (no) 2006-09-22
EP1708726A1 (en) 2006-10-11
US20090175969A1 (en) 2009-07-09
PL209905B1 (pl) 2011-11-30
AU2005205031A1 (en) 2005-07-28
WO2005067952A8 (en) 2005-11-03
WO2005067952A1 (en) 2005-07-28
JP2007517830A (ja) 2007-07-05
KR100826863B1 (ko) 2008-05-06
ATE411033T1 (de) 2008-10-15
CA2584191A1 (en) 2005-07-28
KR20070009562A (ko) 2007-01-18
RU2334523C2 (ru) 2008-09-27
PL364411A1 (en) 2005-07-25

Similar Documents

Publication Publication Date Title
ATE411033T1 (de) Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom
EP3444242A3 (en) Novel benzopyran kinase modulators
WO2009001362A3 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
BR112014008328A2 (pt) mecanismo de entrega nasal para uso profilático e pós-agudo de progesterona e/ou seu enantiômero para uso no tratamento de traumatismos crânio-encefálico leves
MY169564A (en) Substituted dihydropyrazolones and their use
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
IL179012A (en) A drug containing cetirizine for the treatment of nasal inflammation, a process for its preparation and use
SI1778680T1 (sl) Spirociklični cikloheksanski derivati
UA100542C2 (ru) Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
EP1942874A4 (en) PLANT-BASED COMPOSITION FOR PONDERAL CONTROL
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
UA94461C2 (ru) Водный экстракт листьев табака и его применение для лечения состояния зависимости
PH12014501823A1 (en) Pharmaceutical composition for treating urinary incontinence and enuresis
WO2004098519A3 (en) Ginkgo biloba extract as a treatment for therapeutic­ induced neurotoxicity
BRPI0520221A2 (pt) uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma
WO2010072774A3 (de) 5-ht2a und 5-ht2b rezeptorantagonisten zur behandlung der spinalkanalstenose
DK1962822T3 (da) Terapi af maligne neoplasier
WO2008110603A3 (en) Concentrate of protein c containing protein s, its preparation and use
MD2904G2 (ru) Применение препарата Gerovital H3 для лечения поражений центральной нервной системы у детей
WO2009114462A3 (en) Local delivery of chemotherapeutic agents to skeletal metastases
WO2008144949A3 (de) Verwendung von marmor zu kosmetischen, pharmazeutischen und landwirtschaftlichen zwecken
WO2011093664A3 (ko) （１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물.
WO2011109104A3 (en) Molecular clone of hiv-1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee